204 related articles for article (PubMed ID: 19152972)
1. The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization.
Freeman I; Cohen S
Biomaterials; 2009 Apr; 30(11):2122-31. PubMed ID: 19152972
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.
Zhou M; Liu Z; Wei Z; Liu C; Qiao T; Ran F; Bai Y; Jiang X; Ding Y
Artif Organs; 2009 Mar; 33(3):230-9. PubMed ID: 19245522
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-beta1 delivery for cartilage tissue engineering.
Cai DZ; Zeng C; Quan DP; Bu LS; Wang K; Lu HD; Li XF
Chin Med J (Engl); 2007 Feb; 120(3):197-203. PubMed ID: 17355821
[TBL] [Abstract][Full Text] [Related]
5. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration.
De la Riva B; Sánchez E; Hernández A; Reyes R; Tamimi F; López-Cabarcos E; Delgado A; Evora C
J Control Release; 2010 Apr; 143(1):45-52. PubMed ID: 19963026
[TBL] [Abstract][Full Text] [Related]
6. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
7. Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors.
Losi P; Briganti E; Magera A; Spiller D; Ristori C; Battolla B; Balderi M; Kull S; Balbarini A; Di Stefano R; Soldani G
Biomaterials; 2010 Jul; 31(20):5336-44. PubMed ID: 20381861
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.
Hao X; Silva EA; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Wärdell E; Brodin LA; Mooney DJ; Sylvén C
Cardiovasc Res; 2007 Jul; 75(1):178-85. PubMed ID: 17481597
[TBL] [Abstract][Full Text] [Related]
9. Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering.
Zhang Y; Cheng X; Wang J; Wang Y; Shi B; Huang C; Yang X; Liu T
Biochem Biophys Res Commun; 2006 May; 344(1):362-9. PubMed ID: 16600180
[TBL] [Abstract][Full Text] [Related]
10. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration.
Egaña JT; Fierro FA; Krüger S; Bornhäuser M; Huss R; Lavandero S; Machens HG
Tissue Eng Part A; 2009 May; 15(5):1191-200. PubMed ID: 18925832
[TBL] [Abstract][Full Text] [Related]
11. Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels.
He S; Xia T; Wang H; Wei L; Luo X; Li X
Acta Biomater; 2012 Jul; 8(7):2659-69. PubMed ID: 22484697
[TBL] [Abstract][Full Text] [Related]
12. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
13. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds.
Zhang Y; Shi B; Li C; Wang Y; Chen Y; Zhang W; Luo T; Cheng X
J Control Release; 2009 Jun; 136(3):172-8. PubMed ID: 19250951
[TBL] [Abstract][Full Text] [Related]
14. Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.
Ohta M; Suzuki Y; Chou H; Ishikawa N; Suzuki S; Tanihara M; Suzuki Y; Mizushima Y; Dezawa M; Ide C
J Biomed Mater Res A; 2004 Dec; 71(4):661-8. PubMed ID: 15505831
[TBL] [Abstract][Full Text] [Related]
15. Growth factors and fibrochondrocytes in scaffolds.
Pangborn CA; Athanasiou KA
J Orthop Res; 2005 Sep; 23(5):1184-90. PubMed ID: 16140199
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of Nanofibrous PVA/Alginate-Sulfate Substrates for Growth Factor Delivery.
Mohammadi S; Ramakrishna S; Laurent S; Shokrgozar MA; Semnani D; Sadeghi D; Bonakdar S; Akbari M
J Biomed Mater Res A; 2019 Feb; 107(2):403-413. PubMed ID: 30485631
[TBL] [Abstract][Full Text] [Related]
17. Microfabrication of channel arrays promotes vessel-like network formation in cardiac cell construct and vascularization in vivo.
Zieber L; Or S; Ruvinov E; Cohen S
Biofabrication; 2014 Jun; 6(2):024102. PubMed ID: 24464741
[TBL] [Abstract][Full Text] [Related]
18. Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect.
Reyes R; De la Riva B; Delgado A; Hernández A; Sánchez E; Évora C
Injury; 2012 Mar; 43(3):334-42. PubMed ID: 22035848
[TBL] [Abstract][Full Text] [Related]
19. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds.
Jaklenec A; Hinckfuss A; Bilgen B; Ciombor DM; Aaron R; Mathiowitz E
Biomaterials; 2008 Apr; 29(10):1518-25. PubMed ID: 18166223
[TBL] [Abstract][Full Text] [Related]
20. Collagenous matrices as release carriers of exogenous growth factors.
Kanematsu A; Yamamoto S; Ozeki M; Noguchi T; Kanatani I; Ogawa O; Tabata Y
Biomaterials; 2004 Aug; 25(18):4513-20. PubMed ID: 15046942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
